U.S. federal trademark · Serial No. 99117612
Pharmaceutical and biological preparations, namely, cell therapy products for the treatment of cancer, autoimmune diseases, infectious diseases, and other medical conditions amenable to cellular therapy, namely, inflammation, neurodegenerative or neurological disorders, cardiovascular diseases, organ fibrosis, genetic or metabolic disorders, cellular senescence, allogeneic transplant rejection, epidermolysis bullosa, aplastic anemia, sickle cell disease; immunotherapeutic preparations, including chimeric antigen receptor T-cell (CAR-T) therapies and other cellular-based treatments, namely, chimeric antigen receptor NK-cell,chimeric antigen receptor HSC, chimeric antigen receptor Monocyte, chimeric antigen receptor dendritic cells, chimeric antigen receptor Macrophage, chimeric antigen receptor tumor-infiltrating lymphocytes, RNA modified tumor-infiltrating lymphocytes, produced by a proprietary method for medical use.
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.